170 related articles for article (PubMed ID: 20338068)
21. Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters.
Shen L; Kondo Y; Guo Y; Zhang J; Zhang L; Ahmed S; Shu J; Chen X; Waterland RA; Issa JP
PLoS Genet; 2007 Oct; 3(10):2023-36. PubMed ID: 17967063
[TBL] [Abstract][Full Text] [Related]
22. Potential Prognostic Role of
Fabrizio FP; Sparaneo A; Fontana A; Mazza T; Graziano P; Pantalone A; Parente P; Centra F; Orlando N; Trombetta D; Torre A; Ferretti GM; Taurchini M; Micco CMD; Maiello E; Fazio VM; Rossi A; Muscarella LA
Cells; 2020 Jun; 9(6):. PubMed ID: 32580473
[TBL] [Abstract][Full Text] [Related]
23. Significant overexpression of SPARC/osteonectin mRNA in pancreatic cancer compared to cancer of the papilla of Vater.
Prenzel KL; Warnecke-Eberz U; Xi H; Brabender J; Baldus SE; Bollschweiler E; Gutschow CA; Hölscher AH; Schneider PM
Oncol Rep; 2006 May; 15(5):1397-401. PubMed ID: 16596217
[TBL] [Abstract][Full Text] [Related]
24. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
Kao RH; Huang LC; Hsu YH
Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040
[TBL] [Abstract][Full Text] [Related]
25. Methylation pattern of oncogene HRAS gene promoter region and its clinical relevance to urocystic tumorigenesis.
Sun XF; Li L; Li XJ; Shen W
Mol Biol Rep; 2012 Aug; 39(8):8431-7. PubMed ID: 22707223
[TBL] [Abstract][Full Text] [Related]
26. Methylation-mediated expression of SPARC is correlated with tumor progression and poor prognosis of breast cancer.
Li XL; Li JL; Qiu DJ; Ma L
Neoplasma; 2022 Jul; 69(4):794-806. PubMed ID: 35400166
[TBL] [Abstract][Full Text] [Related]
27. Frequent inactivation of hSRBC in ovarian cancers by promoter CpG island hypermethylation.
Tong SY; Ki KD; Lee JM; Kang MJ; Ha TK; Chung SI; Chi SG; Lee SK
Acta Obstet Gynecol Scand; 2010 May; 89(5):629-35. PubMed ID: 20423276
[TBL] [Abstract][Full Text] [Related]
28. NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer.
Liu M; Peng Y; Wang X; Guo Q; Shen S; Li G
BMC Cancer; 2010 Apr; 10():160. PubMed ID: 20423473
[TBL] [Abstract][Full Text] [Related]
29. MiR-377 reverses cancerous phenotypes of pancreatic cells via suppressing DNMT1 and demethylating tumor suppressor genes.
Azizi M; Fard-Esfahani P; Mahmoodzadeh H; Fazeli MS; Azadmanesh K; Zeinali S; Teimoori-Toolabi L
Epigenomics; 2017 Aug; 9(8):1059-1075. PubMed ID: 28758420
[TBL] [Abstract][Full Text] [Related]
30. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
[TBL] [Abstract][Full Text] [Related]
31. Aberrant methylation of SPARC in human lung cancers.
Suzuki M; Hao C; Takahashi T; Shigematsu H; Shivapurkar N; Sathyanarayana UG; Iizasa T; Fujisawa T; Hiroshima K; Gazdar AF
Br J Cancer; 2005 Mar; 92(5):942-8. PubMed ID: 15756262
[TBL] [Abstract][Full Text] [Related]
32. Abrogation of DUSP6 by hypermethylation in human pancreatic cancer.
Xu S; Furukawa T; Kanai N; Sunamura M; Horii A
J Hum Genet; 2005; 50(4):159-167. PubMed ID: 15824892
[TBL] [Abstract][Full Text] [Related]
33. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
34. Cancer specific promoter CpG Islands hypermethylation of HOP homeobox (HOPX) gene and its potential tumor suppressive role in pancreatic carcinogenesis.
Waraya M; Yamashita K; Katoh H; Ooki A; Kawamata H; Nishimiya H; Nakamura K; Ema A; Watanabe M
BMC Cancer; 2012 Sep; 12():397. PubMed ID: 22958219
[TBL] [Abstract][Full Text] [Related]
35. CpG island methylation status in the EpCAM promoter region and gene expression.
Yu G; Zhang X; Wang H; Rui D; Yin A; Qiu G; He Y
Oncol Rep; 2008 Nov; 20(5):1061-7. PubMed ID: 18949402
[TBL] [Abstract][Full Text] [Related]
36. Hypermethylation and clinicopathological significance of RASAL1 gene in gastric cancer.
Chen H; Pan Y; Cheng ZY; Wang Z; Liu Y; Zhao ZJ; Fan H
Asian Pac J Cancer Prev; 2013; 14(11):6261-5. PubMed ID: 24377515
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic regulation of human riboflavin transporter 2(hRFT2) in cervical cancers from Uighur women.
Ma JQ; Kurban S; Zhao JD; Li QZ; Hasimu A
Asian Pac J Cancer Prev; 2014; 15(6):2485-9. PubMed ID: 24761851
[TBL] [Abstract][Full Text] [Related]
38. Association of low p16INK4a and p15INK4b mRNAs expression with their CpG islands methylation with human hepatocellular carcinogenesis.
Qin Y; Liu JY; Li B; Sun ZL; Sun ZF
World J Gastroenterol; 2004 May; 10(9):1276-80. PubMed ID: 15112341
[TBL] [Abstract][Full Text] [Related]
39. DNA methylation of SPARC and chronic low back pain.
Tajerian M; Alvarado S; Millecamps M; Dashwood T; Anderson KM; Haglund L; Ouellet J; Szyf M; Stone LS
Mol Pain; 2011 Aug; 7():65. PubMed ID: 21867537
[TBL] [Abstract][Full Text] [Related]
40. Early epigenetic downregulation of WNK2 kinase during pancreatic ductal adenocarcinoma development.
Dutruel C; Bergmann F; Rooman I; Zucknick M; Weichenhan D; Geiselhart L; Kaffenberger T; Rachakonda PS; Bauer A; Giese N; Hong C; Xie H; Costello JF; Hoheisel J; Kumar R; Rehli M; Schirmacher P; Werner J; Plass C; Popanda O; Schmezer P
Oncogene; 2014 Jun; 33(26):3401-10. PubMed ID: 23912455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
